Nuvalent
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nuvalent and other ETFs, options, and stocks.About NUVL
Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC.
CEOJames R. Porter, PhD
CEOJames R. Porter, PhD
Employees142
Employees142
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2017
Founded2017
Employees142
Employees142
NUVL Key Statistics
Market cap7.90B
Market cap7.90B
Price-Earnings ratio-20.57
Price-Earnings ratio-20.57
Dividend yield—
Dividend yield—
Average volume1.08M
Average volume1.08M
High today$109.46
High today$109.46
Low today$107.19
Low today$107.19
Open price$108.78
Open price$108.78
Volume326.06K
Volume326.06K
52 Week high$112.88
52 Week high$112.88
52 Week low$55.54
52 Week low$55.54
Stock Snapshot
Nuvalent(NUVL) stock is priced at $109.35, giving the company a market capitalization of 7.9B. It carries a P/E multiple of -20.57.
As of 2025-11-30, Nuvalent(NUVL) stock has fluctuated between $107.19 and $109.46. The current price stands at $109.35, placing the stock +2.0% above today's low and -0.1% off the high.
The Nuvalent(NUVL)'s current trading volume is 326.06K, compared to an average daily volume of 1.08M.
During the past year, Nuvalent(NUVL) stock moved between $55.54 at its lowest and $112.88 at its peak.
During the past year, Nuvalent(NUVL) stock moved between $55.54 at its lowest and $112.88 at its peak.
Analyst ratings
100%
of 18 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own NUVL. This list is generated using Robinhood data, and it’s not a recommendation.